StockVS

Lichen International Limited (LICN) Stock Analysis

Industrials

Lichen International Limited

$1.08

+$0.24 (+28.51%)

Last Updated: May 26, 2026

Price History

Analysis

Company Overview

Lichen International Limited operates as an investment holding company that provides specialized services within the People's Republic of China, focusing on financial and taxation management, education support, and software maintenance. The company functions within the Industrials sector and the Specialty Business Services industry, positioning itself to offer management consultation on internal controls and annual financial reporting tasks. Its scale is defined by a market capitalization of $98.45M, an annual revenue of $37.64M, and a workforce of 452 employees. These valuation and operational figures indicate a mid-sized entity within its niche, where the market cap suggests a smaller market valuation relative to its revenue base, while the employee count reflects a substantial operational footprint for a company in the specialty services space.

Financial Health

The company generated revenue of $37.64M over the trailing twelve months, yet reported a net income of -$16,262,000 and an EBITDA of -$10,459,000, revealing a significant gap between top-line growth and profitability driven by high operating costs or non-recurring expenses. Despite the net loss, the company maintains positive financial flexibility with free cash flow of $540,200, which allows for operational continuity despite the erosion of net income by non-cash or structural costs. The gross margin stands at 56.6%, indicating efficient production or service delivery costs, while the operating margin of -36.8% and profit margin of -43.2% demonstrate that overhead expenses and taxes significantly erode the gross profit before reaching the bottom line. The balance sheet exhibits a conservative structure with cash holdings of $22.57M vastly exceeding total debt of $357,000, supported by a debt-to-equity ratio of 0.56 that suggests low leverage relative to shareholder equity. Short-term liquidity is exceptionally strong, evidenced by a current ratio of 10.19, which indicates the company holds more than ten times the current assets necessary to cover its immediate liabilities. However, the return on equity is -24.0% and the return on assets is -10.3%, metrics that reveal management has not yet generated positive returns on the capital deployed, reflecting the ongoing challenges in translating revenue into net earnings.

Valuation Assessment

The trailing P/E ratio is listed as N/A and the forward P/E is also N/A, implying that traditional earnings-based valuation multiples are currently unavailable due to the reported net losses rather than a difference in earnings trajectories. The price-to-book ratio is 0.07, which indicates that the market values the company at a fraction of its book value, suggesting a deep discount relative to the net asset position rather than a market premium. Alternative valuation metrics such as the price-to-sales ratio of 2.62 and an EV/EBITDA of 1.69 provide context, showing that the stock is priced at 2.62 times its sales while the enterprise value remains low relative to EBITDA due to the negative earnings profile. The 52-week high was $8.28 and the 52-week low was $2.57, placing the current trading price in a range that reflects significant volatility and a distance from recent highs. The beta of 1.07 indicates that the stock's price volatility moves in tandem with the broader market, exhibiting slightly higher sensitivity than the index without being excessively leveraged.

Growth & Income

Revenue growth year-over-year was -21.2%, while earnings growth is N/A, indicating that the company is currently contracting rather than expanding its revenue base. Since the earnings growth metric is N/A and revenue is declining, it is impossible to determine if earnings are growing faster or slower than revenue, as the firm is operating with negative earnings and negative revenue growth. The company does not pay a dividend, with a dividend yield of N/A and a payout ratio of 0.0%, meaning it reinvests any available cash flow or retains earnings to fund operations rather than distributing income to shareholders. Consequently, the overall growth and income profile is characterized by negative revenue expansion and zero dividend distribution, relying entirely on operational improvements to reverse the current contraction and negative returns on capital.

Peer Comparison

Lichen International Limited (LICN) operates in the Specialty Business Services industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Lichen International Limited LICN $17.75M N/A
Cintas Corporation CTAS $68.46B 36.1
RELX PLC RELX $58.35B 21.9
Thomson Reuters Corporation TRI.TO $50.46B 24.1

The Specialty Business Services industry average P/E ratio is 65.9x. Lichen International Limited trades at a P/E of N/A.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About Lichen International Limited

Lichen International Limited, an investment holding company, provides financial and taxation, education support, and software and maintenance services in the People's Republic of China. It offers financial and taxation-related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation services; and education support services, including marketing, operational, and technical support, as well as the sale of teaching and learning materials. The company also provides software and maintenance services, including the sale of financial and taxation analysis software, and financial and taxation training software, as well as offers software installation, training, and after-sales technical and maintenance support services. It serves listed companies, state-owned enterprises, government authorities, and other business enterprises, including small and medium-sized enterprises. The company was formerly known as Lichen China Limited and changed its name to Lichen International Limited in March 2025. Lichen International Limited was incorporated in 2016 and is based in Xiamen, China.

Visit website →

Key Statistics

Market Cap
$17.75M
P/E Ratio
N/A
52-Week High
$9.49
52-Week Low
$0.75
Avg Volume
180.44K
Beta
-0.87

Data provided by Yahoo Finance via yfinance. Updated daily.

Company Info

Exchange
NASDAQ
Country
China
Employees
410